Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit

By Meghan Kelly · December 15, 2020, 5:46 PM EST

Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017

Case Title

KPH Healthcare Services, Inc. v. Mylan N.V. et al

Case Number

2:20-cv-02065

Court

Kansas

Nature of Suit

Anti-Trust

Date Filed

February 14, 2020

Featured Stories

NC Legislation Highlights Of The 1st Half Of 2025 No Photo Available

Hayley Fowler

The North Carolina General Assembly has pushed through another round of hurricane relief aid to help the western swath of the state wh... (more story)

This Week's Healthcare Earnings: UnitedHealth, AstraZeneca No Photo Available

Yeji Jesse Lee

A host of companies posted their second-quarter financial results this past week, offering a look into how health systems, payors and ... (more story)

9th Circ. Clarifies Kickback Boundaries For Referral Bonuses No Photo Available

Dan McKay

A Ninth Circuit opinion affirming a California man's fraud conviction provides some clarity — and a warning — to the owners of medical... (more story)